13-(2-iodophenyl)-1,4,7,10-tetraoxa-13-azacyclopentadecane (2)
In a round-bottom flask fitted with a reflux condenser, compound 1 (0.5 g, 1.63 mmol) and di-tosylate (0.60 g, 1.30 mmol) were dissolved in THF (40 mL). NaH (0.31 g, 13.04 mmol) was slowly added to the mixture, which was then stirred at reflux for 3 days. After cooling to room temperature, the solution was concentrated under reduced pressure to afford a residue. The residue was extracted with water and EtOAc. The combined organic layers were dried over anhydrous Na 2 SO 4 and then filtered; the filtrate was concentrated under reduced pressure to obtain the residue. The residue was purified over silica gel to afford 2 (137 mg, 20%). 1 H NMR (400 MHz, Chloroform-d) δ 7.82 (dd, J = 7.9, 1.4 Hz, 1H), 7.33 -7.25 (m, 2H), 6.77 (ddd, J = 7.9, 6.7, 2.1 Hz, 1H), 3.69 (s, 4H), 3.68 -3.58 (m, 12H), 3.38 (t, J = 6.2 Hz, 4H), 13 C NMR (101 MHz, CHLOROFORM-D) δ 152. 92, 139.99, 128.91, 125.85, 125.40, 100.83, 70.95, 70.73, 70.57, 70.45, 54.47 (2-(1,4,7 ,10-tetraoxa-13-azacyclopentadecan-13-yl)phenyl)ethynyl)phenyl)-3-hexylurea (4) 3a (160 mg, 0.712 ,mmol) and tributyltin methoxide (0.056 mL, 2.13 mmol) were charged in a pressure bottle. The solution was stirred at 120 o C for 4 h. The resulting solution of 3b was used without purification. To a well stirred solution of 2 (200 mg, 0.475 mmol) in DMF (4 mL), Pd(PPh 3 ) 4 (37 mg, 0.0475 mmol) and the solution of 3b was added and then flushed with argon for 5-10 min. The soultion was stirred at 70 o C for 5h. After cooling to room temperature, the solution was concentrated under reduced pressure to afford a residue. The residue was extracted with water and EtOAc. The combined organic layers were dried over anhydrous Na 2 SO 4 and then filtered; the filtrate was concentrated under reduced pressure to obtain the residue. The residue was purified over silica gel to afford 4 (66 mg, 26%). 1 H NMR (400 MHz, Acetone-d 6 ) δ 8.24 (dd, J = 8.5, 1.2 Hz, 1H), 7.69 (s, 1H), 7.44 (ddd, J = 7.7, 1.6, 0.5 Hz, 1H), 7.41 (dd, J = 7.7, 1.7 Hz, 1H), 7.29 -7.21 (m, 2H), 7.08 (dd, J = 8.5, 1.1 Hz, 1H), 6.93 (td, J = 7.6, 1.2 Hz, 1H), 6.83 (td, J = 7.4, 1.1 Hz, 1H), 6.41 (s, 1H), 3.78 -3.63 (m, 8H), 3.60 -3.49 (m, 12H), 3.19 (td, J = 7.0, 5.7 Hz, 2H), 1.57 -1.42 (m, 2H), 1.38 -1.21 (m, 6H), 0.85 (t, J = 7.0 Hz, 3H), 13 C NMR (101 MHz, ACETONE-D 6 ) δ 155. 73, 153.11, 142.23, 136.10, 132.76, 130.45, 129.89, 122.08, 120.62, 119.97, 119.67, 114.67, 112.73, 96.15, 90.26, 71.76, 71.11, 70.75, 54.07, 40.62, 40.50, 32.44, 31.03, 27.46, 23.39, 14.42 
1-(2-(

Spectroscopic titrations
Stock solutions of all of the compounds studied were made up in CH 3 CN with the final concentrations being between 2.0 × 10 -5 M. ACS grade solvents were purchased and used without purification. The stock solutions were appropriately diluted with the solvents for the ensuing studies.
Binding Constants by UV-vis titrations
Upon addition of incremental amounts of anions to the solution of receptor 4, absorbance change of 4 (2.0× 10 -5 M of 4 was used, unless otherwiswe stated) were recorded in CH 3 CN. Equilibrium constants of complexes were calculated using the equation 
Binding constants by fluorescent titrations
Upon addition of incremental amounts of anion to the solution of receptor 4, fluorescence change of each chemosensor (2.0 × 10 -5 M ) were recorded in CH 3 CN by irradiating the solution at λ ex = 340 nm. Equilibrium constants of complexes were calculated using the equation below. 
Quantum Yields
